Cantor Fitzgerald Predicts MIRM FY2026 Earnings
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) – Analysts at Cantor Fitzgerald issued their FY2026 EPS estimates for shares of Mirum Pharmaceuticals in a research report issued on Monday, June 9th. Cantor Fitzgerald analyst J. Schimmer forecasts that the company will post earnings per share of ($0.92) for the year. The consensus estimate for Mirum […]
